Építés alatt – nem éles oldal
Belépés
Még nem keres résztvevőt itt: KínaFázis nélkül

Safety and Effectiveness of Unilateral MR-Guided Focused Ultrasound Thalamotomy for Essential Tremor

A legfontosabb adatok

Ki végzi
meishanshan
Hol
Beijing (Kína)A helyszín megnézése
Azonosító
Állapot
Toborzás még nem indult
Résztvevők
100 fő, tervezett
Kezdés
2025. jún. 10.
Várható befejezés
2027. jún. 10.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A vizsgált kezelések
  • MR-guided Focused Ultrasound Thalamotomy
A regiszteradat frissítve
2025. június 5.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with essential tremor whose tremor stays serious despite medicine. Participants either get focused ultrasound treatment on one side of the brain or standard medicine.

Életkor
22 years or older
Nem
All sexes
A betegség stádiuma
Essential tremor confirmed by clinical criteria, with significant problems in daily function
Korábbi kezelés
Tremor must not have improved enough with medication

A részvétel fő kizáró okai

  • Other neurological disorders, such as Parkinson's disease
  • Unstable medical conditions, such as uncontrolled high blood pressure
  • Cannot have an MRI, for example because of implanted metal devices
  • Severe memory or thinking problems, or psychiatric illness
  • Pregnancy or breastfeeding

A regiszter feltételei, szó szerint

Mind a 10 feltétel megnézéseKevesebb

Ki vehet részt

  • Age ≥ 22 years
  • Diagnosis of essential tremor confirmed by clinical criteria
  • Medication-refractory tremor with significant functional impairment
  • Ability to provide informed consent
  • Willingness to undergo follow-up assessments for 12 months

Ki nem vehet részt

  • History of other neurological disorders (e.g., Parkinson's disease)
  • Presence of unstable medical conditions (e.g., uncontrolled hypertension)
  • Severe cognitive impairment or psychiatric illness
  • Contraindications to MRI (e.g., implanted metal devices)
  • Pregnancy or breastfeeding

Helyszínek itt: Kína

  • Beijing GoBroad HospitalBeijing, KínaContact: Ling ChenToborzás még nem indult

A vizsgálatról

Mit akar kideríteni a vizsgálat

Essential tremor (ET) is one of the most common movement disorders, significantly impacting patients' quality of life. Many patients do not respond well to medication or cannot tolerate side effects, leaving limited treatment options. Magnetic Resonance-guided Focused Ultrasound (MRgFUS) is a noninvasive, targeted therapy that offers a promising alternative to surgical procedures such as deep brain stimulation.

A teljes eredeti leírásKevesebb

This study is a multicenter, non-randomized controlled observational study designed to evaluate the safety and effectiveness of unilateral MRgFUS thalamotomy targeting the ventral intermediate nucleus (VIM) in patients with medication-refractory essential tremor. Participants will be divided into two groups based on clinical evaluation and patient preference: the treatment group receiving MRgFUS and the control group receiving standard medical therapy. Both groups will undergo regular follow-up for one year.

The primary outcome is improvement in tremor severity as measured by the Fahn-Tolosa-Marin Tremor Rating Scale and the Clinical Rating Scale for Tremor. Secondary outcomes include quality of life, cognitive and emotional status, and treatment-related adverse events.

Eligible participants are adults aged 22 years or older who have a confirmed diagnosis of essential tremor and are significantly impaired despite medication. The goal is to assess whether MRgFUS provides sustained tremor relief and improves quality of life in comparison to standard care, while maintaining an acceptable safety profile.

A vizsgálat 2 csoportja

  • MRgFUS Group

    Participants in this group will undergo unilateral MR-guided focused ultrasound (MRgFUS) thalamotomy targeting the ventral intermediate nucleus (VIM) of the thalamus. The procedure is non-invasive and performed under MRI guidance. Subjects will be followed prospectively for 12 months to assess changes in tremor severity, quality of life, and safety outcomes.

    Kezelés: MR-guided Focused Ultrasound Thalamotomy

  • Medical Therapy Group

    Participants in this group will receive standard medical therapy for essential tremor, which may include beta-blockers (such as propranolol), primidone, or other clinically indicated medications. Treatment plans will be determined by the attending physicians according to routine clinical practice. Participants will be followed for 12 months to assess changes in tremor severity, quality of life, and safety outcomes, consistent with the surgical treatment group.

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Multicenter, Non-Randomized Controlled Observational Study on the Safety and Effectiveness of Unilateral MR-Guided Focused Ultrasound Thalamotomy for Essential Tremor
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2025. június 5.